Mohamed Mahmoud H A, Abdelaziz Adel M, Kumar Sachin, Al-Habib Malik A, Megahed Mohamed M
a Department of Clinical Studies, Collage of Veterinary Medicine and Animal Resources , King Faisal University , Al-Hasa , Saudi Arabia.
b Deaprtment of Avian and Rabbit Medicine, Faculty of Veterinary Medicine , Zagazig University , Zagazig , Egypt.
Avian Pathol. 2016;45(2):228-34. doi: 10.1080/03079457.2016.1144870.
Newcastle disease (ND) is a highly devastating disease for the poultry industry as it causes high economic losses. In this present study, a DNA vaccine containing the F and HN surface antigens of a highly virulent Newcastle disease virus (NDV), NDV/1/Chicken/2005 (FJ939313), was successfully generated. Cell transfection test indicated that the vaccine expressed the F and HN genes in Hep-2 cells. The main objective of this study was to compare the extent of protection induced by DNA vaccination after homologous and heterologous NDV-challenge as determined by the amount of NDV shedding after challenge. NDV-antibody-negative chickens were vaccinated either once, twice or thrice intramuscularly at 7, 14 and 21 days old and were challenged 14 days post vaccination with either homologous virus (vaccine-matched velogenic viscerotropic Newcastle disease virus (vvNDV) strain, FJ939313), phylogenetically related to group VII, or a phylogenetically divergent heterologous virus (unmatched vvNDV strain, AY968809), which belongs to genogroup VI and shows 84.1% nucleotide similarity to the NDV-sequences of the DNA vaccine. Our data indicate that birds, which received a single dose of the DNA vaccine were poorly protected, and only 30-40% of these birds survived after challenge with high virus shedding titre. Multiple administration of the DNA vaccine induced high protection rates of 70-90% with reduced virus shedding compared to the non-vaccinated and challenged birds. Generally, homologous challenge led to reduced tracheal and cloacal shedding compared to the heterologous vvNDV strain. This study provides a promising approach for the control of ND in chickens using DNA vaccines, which are phylogenetically closely related to the circulating field strains.
新城疫(ND)对家禽业是一种极具毁灭性的疾病,会造成巨大的经济损失。在本研究中,成功构建了一种包含高致病性新城疫病毒(NDV)NDV/1/Chicken/2005(FJ939313)的F和HN表面抗原的DNA疫苗。细胞转染试验表明该疫苗在Hep-2细胞中表达了F和HN基因。本研究的主要目的是比较同源和异源NDV攻击后DNA疫苗诱导的保护程度,通过攻击后NDV的排毒量来确定。NDV抗体阴性的鸡在7、14和21日龄时分别进行一次、两次或三次肌肉注射疫苗,并在接种疫苗后14天用同源病毒(与疫苗匹配的速发型嗜内脏新城疫病毒(vvNDV)株FJ939313,与VII组系统发育相关)或系统发育不同的异源病毒(不匹配的vvNDV株AY968809,属于基因群VI,与DNA疫苗的NDV序列显示84.1%的核苷酸相似性)进行攻击。我们的数据表明,接受单剂量DNA疫苗的鸡受到的保护较差,在高病毒排毒滴度攻击后,这些鸡中只有30 - 40%存活。与未接种疫苗且受到攻击的鸡相比,多次接种DNA疫苗诱导的保护率高达70 - 90%,且病毒排毒减少。一般来说,与异源vvNDV株相比,同源攻击导致气管和泄殖腔排毒减少。本研究为使用与流行的田间毒株系统发育密切相关的DNA疫苗控制鸡新城疫提供了一种有前景的方法。